CME Group (NASDAQ:CME) Rating Upgrade
Research professionals at Goldman Sachs’s research division boosted CME Group (NASDAQ:CME)’s Stock from Neutral to Buy on Wednesday, 7 February. The analysts at Goldman Sachs have a price target of $180.0 on CME or 14.18 % more upside.
The stock upgrade is welcomed by stock speculators, as NASDAQ:CME is right now trading 0.17% higher at $123.37 as of 4:08 AM New York time. CME Group shares have [From2] 0% in the last 200 days, while the S&P500 Index has gained 6.00% in the same time period.
According to data compiled by Thomson Reuters, CME Group (NASDAQ:CME)’s stock is covered by 15 equity analysts across the Street, with 0 analysts giving it a Sell rating, 0 a Buy rating, while 0 consider it a Hold. The 12-month consensus target price for the stock is $99.53, which reflects an downside potential of 19.32% over the current price.
Vgi Partners Pty Ltd had the biggest stake with ownership of 669,068 shares as of Q2 2015 for 18.21% of the Stock Exposure. Iron Financial Llc is another quite bullish fund who is possessing 91,951 shares of CME Group or 11.73% of their stock exposure. Furthermore, Capital Counsel Llc Ny have 8.23% of their stock exposure invested in the company for 882,417 shares. The Ohio-based fund Cincinnati Financial Corp revealed it had acquired a stake worth about 5.66% of the fund’s stock portfolio in CME Group. The Nebraska-based fund America First Investment Advisors Llc is also positive about the stock, possessing 975,000 shares or 4.87% of their stock exposure.
CME Group (NASDAQ:CME) Profile
CME Group Inc., through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX) exchanges. The Company provides electronic trading around the globe on its CME Globex platform.
CME Group (NASDAQ:CME) traded up 0.17% on 7 February, hitting $123.37. A total of 141,077 shares of the company’s stock traded hands. This is down from average of 1.28 million shares. CME Group has a 52 week low of $98.95 and a 52 week high of $127.96. The company has a market cap of $41.60 billion and a P/E ratio of 26.73.
Get the latest CME Group (NASDAQ:CME) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post CME Group (NASDAQ:CME) Buy Rating With $180.0 Target Price by Analysts at Goldman Sachs from Neutral Rating appeared first on Octafinance.